Erectile dysfunction (ED) is a common sexual health issue affecting men worldwide, characterized by the inability to achieve or maintain an erection sufficient for sexual activity. Over the years, treatment options have evolved, with phosphodiesterase type 5 (PDE5) inhibitors emerging as the cornerstone of therapy. Malegra Oral Jelly, containing sildenafil citrate as its active ingredient, is a modern and convenient form of PDE5 inhibitor therapy. Unlike traditional tablets, Malegra Oral Jelly is available in a flavored gel form that is easy to swallow and quickly absorbed through the mucous membranes in the mouth. This results in a faster onset of action, often within 15–30 minutes, compared to 30–60 minutes for standard tablets.